California Public Employees Retirement System lowered its position in shares of Elizabeth Arden Inc. (NASDAQ:RDEN) by 6.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 170,000 shares of the company’s stock after selling 12,600 shares during the period. California Public Employees Retirement System owned 0.57% of Elizabeth Arden worth $2,339,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Royce & Associates LP boosted its stake in shares of Elizabeth Arden by 7.7% in the first quarter. Royce & Associates LP now owns 1,240,894 shares of the company’s stock worth $10,163,000 after buying an additional 89,102 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Elizabeth Arden during the second quarter worth $11,776,000. State Street Corp boosted its stake in shares of Elizabeth Arden by 3.8% in the first quarter. State Street Corp now owns 405,292 shares of the company’s stock worth $3,320,000 after buying an additional 14,867 shares during the last quarter. Longfellow Investment Management Co. LLC acquired a new stake in shares of Elizabeth Arden during the second quarter worth $4,753,000. Finally, Kassirer Asset Management Corp acquired a new stake in shares of Elizabeth Arden during the second quarter worth $3,612,000. Institutional investors and hedge funds own 70.70% of the company’s stock.
Elizabeth Arden Inc. (NASDAQ:RDEN) remained flat at $13.98 during trading on Monday. Elizabeth Arden Inc. has a 1-year low of $5.02 and a 1-year high of $14.14. The stock has a 50-day moving average price of $13.93 and a 200-day moving average price of $10.50.
Elizabeth Arden (NASDAQ:RDEN) last announced its earnings results on Wednesday, August 10th. The company reported ($0.58) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.78) by $0.20. Elizabeth Arden had a negative net margin of 7.43% and a negative return on equity of 38.72%. The company earned $192.70 million during the quarter, compared to the consensus estimate of $193.75 million. On average, equities research analysts forecast that Elizabeth Arden Inc. will post ($0.49) earnings per share for the current fiscal year.
A number of research firms recently commented on RDEN. B. Riley reaffirmed a “neutral” rating and issued a $14.00 price objective on shares of Elizabeth Arden in a research note on Sunday, September 25th. Zacks Investment Research raised shares of Elizabeth Arden from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a research note on Tuesday, August 16th. Finally, Imperial Capital reaffirmed an “outperform” rating and issued a $14.00 price objective on shares of Elizabeth Arden in a research note on Wednesday, June 8th.
Elizabeth Arden Company Profile
Elizabeth Arden, Inc is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company’s product portfolio includes Elizabeth Arden Brand, such as the Elizabeth Arden skin care brands (Visible Difference, Ceramide, Prevage, Eight Hour Cream, Superstart and Elizabeth Arden Pro), Elizabeth Arden branded lipstick, foundation and other color cosmetics products and Elizabeth Arden fragrances (Red Door, 5th Avenue, Elizabeth Arden Green Tea and UNTOLD); designer fragrances, which include Juicy Couture, John Varvatos, and Wildfox Couture; Heritage Fragrances, such as Curve, Elizabeth Taylor, Britney Spears, Halston, Ed Hardy, Geoffrey Beene, Alfred Sung, Giorgio Beverly Hills, Lucky, PS Fine Cologne, White Shoulders, BCBGMAXAZRIA, Rocawear and Jennifer Aniston, and celebrity fragrances, which include the fragrance brands of Justin Bieber, Mariah Carey, Nicki Minaj and Taylor Swift.
Want to see what other hedge funds are holding RDEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elizabeth Arden Inc. (NASDAQ:RDEN).
Receive News & Ratings for Elizabeth Arden Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elizabeth Arden Inc. and related companies with MarketBeat.com's FREE daily email newsletter.